Clinical Trial Drug Sourcing refers to the specialized services provided by enterprises or organizations to facilitate the procurement, management and distribution of clinical trial investigation drugs and related supplies. These services help streamline the drug procurement process, reduce risk and ensure compliance with regulatory requirements, and are critical to ensuring researchers have access to the necessary drugs and materials they need to conduct their studies effectively and safely.
The global Clinical Trial Drug Sourcing market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淐linical Trial Drug Sourcing Industry Forecast鈥� looks at past sales and reviews total world Clinical Trial Drug Sourcing sales in 2022, providing a comprehensive analysis by region and market sector of projected Clinical Trial Drug Sourcing sales for 2023 through 2029. With Clinical Trial Drug Sourcing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Trial Drug Sourcing industry.
This Insight Report provides a comprehensive analysis of the global Clinical Trial Drug Sourcing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Clinical Trial Drug Sourcing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Clinical Trial Drug Sourcing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Trial Drug Sourcing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Trial Drug Sourcing.
United States market for Clinical Trial Drug Sourcing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Clinical Trial Drug Sourcing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Clinical Trial Drug Sourcing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Clinical Trial Drug Sourcing players cover Patheon (Thermo Fisher Scientific), McKesson, Sharp Services, Almac Group, Myonex, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Trial Drug Sourcing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Direct Sourcing
Open 麻豆原创 Sourcing
Segmentation by Application:
CRO
Biotech Firms
Research Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Direct Sourcing
Open 麻豆原创 Sourcing
Segmentation by Application:
CRO
Biotech Firms
Research Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Patheon (Thermo Fisher Scientific)
McKesson
Sharp Services
Almac Group
Myonex
Clinigen
Clinical Services International (CSI)
Cencora
Euromed Pharma
ICON
RxSource
Bionic Emas
IQVIA
WEP Clinical
EarlyHealth Group
Catalent
Inceptua
NewLife Medicals
Yourway
BMclinical (BModesto)
Firstline Pharma
ClientPharma
Tanner Pharma
Alcura Health
Midwest Pharmaceuticals
ADAllen Pharma
Neunco
Jean Standard Biological
Memorial Pharmaceutical
Clinschain
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Clinical Trial Drug Sourcing 麻豆原创 Size 2019-2030
2.1.2 Clinical Trial Drug Sourcing 麻豆原创 Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Clinical Trial Drug Sourcing by Country/Region, 2019, 2023 & 2030
2.2 Clinical Trial Drug Sourcing Segment by Type
2.2.1 Direct Sourcing
2.2.2 Open 麻豆原创 Sourcing
2.3 Clinical Trial Drug Sourcing 麻豆原创 Size by Type
2.3.1 Clinical Trial Drug Sourcing 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Clinical Trial Drug Sourcing 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Clinical Trial Drug Sourcing Segment by Application
2.4.1 CRO
2.4.2 Biotech Firms
2.4.3 Research Institutes
2.4.4 Others
2.5 Clinical Trial Drug Sourcing 麻豆原创 Size by Application
2.5.1 Clinical Trial Drug Sourcing 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Clinical Trial Drug Sourcing 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Clinical Trial Drug Sourcing 麻豆原创 Size by Player
3.1 Clinical Trial Drug Sourcing 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Clinical Trial Drug Sourcing Revenue by Player (2019-2024)
3.1.2 Global Clinical Trial Drug Sourcing Revenue 麻豆原创 Share by Player (2019-2024)
3.2 Global Clinical Trial Drug Sourcing Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Clinical Trial Drug Sourcing by Region
4.1 Clinical Trial Drug Sourcing 麻豆原创 Size by Region (2019-2024)
4.2 Global Clinical Trial Drug Sourcing Annual Revenue by Country/Region (2019-2024)
4.3 Americas Clinical Trial Drug Sourcing 麻豆原创 Size Growth (2019-2024)
4.4 APAC Clinical Trial Drug Sourcing 麻豆原创 Size Growth (2019-2024)
4.5 Europe Clinical Trial Drug Sourcing 麻豆原创 Size Growth (2019-2024)
4.6 Middle East & Africa Clinical Trial Drug Sourcing 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Clinical Trial Drug Sourcing 麻豆原创 Size by Country (2019-2024)
5.2 Americas Clinical Trial Drug Sourcing 麻豆原创 Size by Type (2019-2024)
5.3 Americas Clinical Trial Drug Sourcing 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Clinical Trial Drug Sourcing 麻豆原创 Size by Region (2019-2024)
6.2 APAC Clinical Trial Drug Sourcing 麻豆原创 Size by Type (2019-2024)
6.3 APAC Clinical Trial Drug Sourcing 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Clinical Trial Drug Sourcing 麻豆原创 Size by Country (2019-2024)
7.2 Europe Clinical Trial Drug Sourcing 麻豆原创 Size by Type (2019-2024)
7.3 Europe Clinical Trial Drug Sourcing 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Clinical Trial Drug Sourcing by Region (2019-2024)
8.2 Middle East & Africa Clinical Trial Drug Sourcing 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Clinical Trial Drug Sourcing 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Clinical Trial Drug Sourcing 麻豆原创 Forecast
10.1 Global Clinical Trial Drug Sourcing Forecast by Region (2025-2030)
10.1.1 Global Clinical Trial Drug Sourcing Forecast by Region (2025-2030)
10.1.2 Americas Clinical Trial Drug Sourcing Forecast
10.1.3 APAC Clinical Trial Drug Sourcing Forecast
10.1.4 Europe Clinical Trial Drug Sourcing Forecast
10.1.5 Middle East & Africa Clinical Trial Drug Sourcing Forecast
10.2 Americas Clinical Trial Drug Sourcing Forecast by Country (2025-2030)
10.2.1 United States 麻豆原创 Clinical Trial Drug Sourcing Forecast
10.2.2 Canada 麻豆原创 Clinical Trial Drug Sourcing Forecast
10.2.3 Mexico 麻豆原创 Clinical Trial Drug Sourcing Forecast
10.2.4 Brazil 麻豆原创 Clinical Trial Drug Sourcing Forecast
10.3 APAC Clinical Trial Drug Sourcing Forecast by Region (2025-2030)
10.3.1 China Clinical Trial Drug Sourcing 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Clinical Trial Drug Sourcing Forecast
10.3.3 Korea 麻豆原创 Clinical Trial Drug Sourcing Forecast
10.3.4 Southeast Asia 麻豆原创 Clinical Trial Drug Sourcing Forecast
10.3.5 India 麻豆原创 Clinical Trial Drug Sourcing Forecast
10.3.6 Australia 麻豆原创 Clinical Trial Drug Sourcing Forecast
10.4 Europe Clinical Trial Drug Sourcing Forecast by Country (2025-2030)
10.4.1 Germany 麻豆原创 Clinical Trial Drug Sourcing Forecast
10.4.2 France 麻豆原创 Clinical Trial Drug Sourcing Forecast
10.4.3 UK 麻豆原创 Clinical Trial Drug Sourcing Forecast
10.4.4 Italy 麻豆原创 Clinical Trial Drug Sourcing Forecast
10.4.5 Russia 麻豆原创 Clinical Trial Drug Sourcing Forecast
10.5 Middle East & Africa Clinical Trial Drug Sourcing Forecast by Region (2025-2030)
10.5.1 Egypt 麻豆原创 Clinical Trial Drug Sourcing Forecast
10.5.2 South Africa 麻豆原创 Clinical Trial Drug Sourcing Forecast
10.5.3 Israel 麻豆原创 Clinical Trial Drug Sourcing Forecast
10.5.4 Turkey 麻豆原创 Clinical Trial Drug Sourcing Forecast
10.6 Global Clinical Trial Drug Sourcing Forecast by Type (2025-2030)
10.7 Global Clinical Trial Drug Sourcing Forecast by Application (2025-2030)
10.7.1 GCC Countries 麻豆原创 Clinical Trial Drug Sourcing Forecast
11 Key Players Analysis
11.1 Patheon (Thermo Fisher Scientific)
11.1.1 Patheon (Thermo Fisher Scientific) Company Information
11.1.2 Patheon (Thermo Fisher Scientific) Clinical Trial Drug Sourcing Product Offered
11.1.3 Patheon (Thermo Fisher Scientific) Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Patheon (Thermo Fisher Scientific) Main Business Overview
11.1.5 Patheon (Thermo Fisher Scientific) Latest Developments
11.2 McKesson
11.2.1 McKesson Company Information
11.2.2 McKesson Clinical Trial Drug Sourcing Product Offered
11.2.3 McKesson Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 McKesson Main Business Overview
11.2.5 McKesson Latest Developments
11.3 Sharp Services
11.3.1 Sharp Services Company Information
11.3.2 Sharp Services Clinical Trial Drug Sourcing Product Offered
11.3.3 Sharp Services Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Sharp Services Main Business Overview
11.3.5 Sharp Services Latest Developments
11.4 Almac Group
11.4.1 Almac Group Company Information
11.4.2 Almac Group Clinical Trial Drug Sourcing Product Offered
11.4.3 Almac Group Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Almac Group Main Business Overview
11.4.5 Almac Group Latest Developments
11.5 Myonex
11.5.1 Myonex Company Information
11.5.2 Myonex Clinical Trial Drug Sourcing Product Offered
11.5.3 Myonex Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Myonex Main Business Overview
11.5.5 Myonex Latest Developments
11.6 Clinigen
11.6.1 Clinigen Company Information
11.6.2 Clinigen Clinical Trial Drug Sourcing Product Offered
11.6.3 Clinigen Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Clinigen Main Business Overview
11.6.5 Clinigen Latest Developments
11.7 Clinical Services International (CSI)
11.7.1 Clinical Services International (CSI) Company Information
11.7.2 Clinical Services International (CSI) Clinical Trial Drug Sourcing Product Offered
11.7.3 Clinical Services International (CSI) Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Clinical Services International (CSI) Main Business Overview
11.7.5 Clinical Services International (CSI) Latest Developments
11.8 Cencora
11.8.1 Cencora Company Information
11.8.2 Cencora Clinical Trial Drug Sourcing Product Offered
11.8.3 Cencora Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Cencora Main Business Overview
11.8.5 Cencora Latest Developments
11.9 Euromed Pharma
11.9.1 Euromed Pharma Company Information
11.9.2 Euromed Pharma Clinical Trial Drug Sourcing Product Offered
11.9.3 Euromed Pharma Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Euromed Pharma Main Business Overview
11.9.5 Euromed Pharma Latest Developments
11.10 ICON
11.10.1 ICON Company Information
11.10.2 ICON Clinical Trial Drug Sourcing Product Offered
11.10.3 ICON Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 ICON Main Business Overview
11.10.5 ICON Latest Developments
11.11 RxSource
11.11.1 RxSource Company Information
11.11.2 RxSource Clinical Trial Drug Sourcing Product Offered
11.11.3 RxSource Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 RxSource Main Business Overview
11.11.5 RxSource Latest Developments
11.12 Bionic Emas
11.12.1 Bionic Emas Company Information
11.12.2 Bionic Emas Clinical Trial Drug Sourcing Product Offered
11.12.3 Bionic Emas Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 Bionic Emas Main Business Overview
11.12.5 Bionic Emas Latest Developments
11.13 IQVIA
11.13.1 IQVIA Company Information
11.13.2 IQVIA Clinical Trial Drug Sourcing Product Offered
11.13.3 IQVIA Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 IQVIA Main Business Overview
11.13.5 IQVIA Latest Developments
11.14 WEP Clinical
11.14.1 WEP Clinical Company Information
11.14.2 WEP Clinical Clinical Trial Drug Sourcing Product Offered
11.14.3 WEP Clinical Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 WEP Clinical Main Business Overview
11.14.5 WEP Clinical Latest Developments
11.15 EarlyHealth Group
11.15.1 EarlyHealth Group Company Information
11.15.2 EarlyHealth Group Clinical Trial Drug Sourcing Product Offered
11.15.3 EarlyHealth Group Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 EarlyHealth Group Main Business Overview
11.15.5 EarlyHealth Group Latest Developments
11.16 Catalent
11.16.1 Catalent Company Information
11.16.2 Catalent Clinical Trial Drug Sourcing Product Offered
11.16.3 Catalent Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.16.4 Catalent Main Business Overview
11.16.5 Catalent Latest Developments
11.17 Inceptua
11.17.1 Inceptua Company Information
11.17.2 Inceptua Clinical Trial Drug Sourcing Product Offered
11.17.3 Inceptua Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.17.4 Inceptua Main Business Overview
11.17.5 Inceptua Latest Developments
11.18 NewLife Medicals
11.18.1 NewLife Medicals Company Information
11.18.2 NewLife Medicals Clinical Trial Drug Sourcing Product Offered
11.18.3 NewLife Medicals Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.18.4 NewLife Medicals Main Business Overview
11.18.5 NewLife Medicals Latest Developments
11.19 Yourway
11.19.1 Yourway Company Information
11.19.2 Yourway Clinical Trial Drug Sourcing Product Offered
11.19.3 Yourway Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.19.4 Yourway Main Business Overview
11.19.5 Yourway Latest Developments
11.20 BMclinical (BModesto)
11.20.1 BMclinical (BModesto) Company Information
11.20.2 BMclinical (BModesto) Clinical Trial Drug Sourcing Product Offered
11.20.3 BMclinical (BModesto) Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.20.4 BMclinical (BModesto) Main Business Overview
11.20.5 BMclinical (BModesto) Latest Developments
11.21 Firstline Pharma
11.21.1 Firstline Pharma Company Information
11.21.2 Firstline Pharma Clinical Trial Drug Sourcing Product Offered
11.21.3 Firstline Pharma Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.21.4 Firstline Pharma Main Business Overview
11.21.5 Firstline Pharma Latest Developments
11.22 ClientPharma
11.22.1 ClientPharma Company Information
11.22.2 ClientPharma Clinical Trial Drug Sourcing Product Offered
11.22.3 ClientPharma Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.22.4 ClientPharma Main Business Overview
11.22.5 ClientPharma Latest Developments
11.23 Tanner Pharma
11.23.1 Tanner Pharma Company Information
11.23.2 Tanner Pharma Clinical Trial Drug Sourcing Product Offered
11.23.3 Tanner Pharma Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.23.4 Tanner Pharma Main Business Overview
11.23.5 Tanner Pharma Latest Developments
11.24 Alcura Health
11.24.1 Alcura Health Company Information
11.24.2 Alcura Health Clinical Trial Drug Sourcing Product Offered
11.24.3 Alcura Health Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.24.4 Alcura Health Main Business Overview
11.24.5 Alcura Health Latest Developments
11.25 Midwest Pharmaceuticals
11.25.1 Midwest Pharmaceuticals Company Information
11.25.2 Midwest Pharmaceuticals Clinical Trial Drug Sourcing Product Offered
11.25.3 Midwest Pharmaceuticals Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.25.4 Midwest Pharmaceuticals Main Business Overview
11.25.5 Midwest Pharmaceuticals Latest Developments
11.26 ADAllen Pharma
11.26.1 ADAllen Pharma Company Information
11.26.2 ADAllen Pharma Clinical Trial Drug Sourcing Product Offered
11.26.3 ADAllen Pharma Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.26.4 ADAllen Pharma Main Business Overview
11.26.5 ADAllen Pharma Latest Developments
11.27 Neunco
11.27.1 Neunco Company Information
11.27.2 Neunco Clinical Trial Drug Sourcing Product Offered
11.27.3 Neunco Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.27.4 Neunco Main Business Overview
11.27.5 Neunco Latest Developments
11.28 Jean Standard Biological
11.28.1 Jean Standard Biological Company Information
11.28.2 Jean Standard Biological Clinical Trial Drug Sourcing Product Offered
11.28.3 Jean Standard Biological Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.28.4 Jean Standard Biological Main Business Overview
11.28.5 Jean Standard Biological Latest Developments
11.29 Memorial Pharmaceutical
11.29.1 Memorial Pharmaceutical Company Information
11.29.2 Memorial Pharmaceutical Clinical Trial Drug Sourcing Product Offered
11.29.3 Memorial Pharmaceutical Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.29.4 Memorial Pharmaceutical Main Business Overview
11.29.5 Memorial Pharmaceutical Latest Developments
11.30 Clinschain
11.30.1 Clinschain Company Information
11.30.2 Clinschain Clinical Trial Drug Sourcing Product Offered
11.30.3 Clinschain Clinical Trial Drug Sourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.30.4 Clinschain Main Business Overview
11.30.5 Clinschain Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
